4//SEC Filing
ELLIS JAMES J 4
Accession 0001179110-11-005345
CIK 0000856982other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 5:37 PM ET
Size
18.7 KB
Accession
0001179110-11-005345
Insider Transaction Report
Form 4
ELLIS JAMES J
Director
Transactions
- Exercise/Conversion
Common Stock, No Par Value
2011-03-18$10.47/sh+26,667$279,203→ 30,918 total - Exercise/Conversion
Nonqualified stock options (rights to buy)
2011-03-18−26,667→ 0 totalExercise: $10.47From: 2003-05-22Exp: 2013-05-22→ Common Stock (26,667 underlying) - Sale
Common Stock, No Par Value
2011-03-18$18.70/sh−26,667$498,673→ 4,251 total
Holdings
- 20,000
Nonqualified stock options (rights to buy)
Exercise: $17.28From: 2010-09-26Exp: 2016-09-26→ Common Stock (20,000 underlying) - 15,000
Nonqualified stock options (rights to buy)
Exercise: $11.52From: 2006-05-25Exp: 2013-05-25→ Common Stock (15,000 underlying) - 15,000
Nonqualified stock options (rights to buy)
Exercise: $14.41From: 2009-05-21Exp: 2015-05-21→ Common Stock (15,000 underlying) - 15,000
Nonqualified stock options (rights to buy)
Exercise: $13.81From: 2004-06-10Exp: 2014-06-10→ Common Stock (15,000 underlying) - 15,000
Nonqualified stock options (rights to buy)
Exercise: $12.13From: 2008-06-27Exp: 2014-06-27→ Common Stock (15,000 underlying) - 20,000
Nonqualified stock options (rights to buy)
Exercise: $16.45From: 2011-06-25Exp: 2017-06-25→ Common Stock (20,000 underlying) - 15,000
Nonqualified stock options (rights to buy)
Exercise: $21.67From: 2003-12-13Exp: 2013-12-13→ Common Stock (15,000 underlying) - 15,000
Nonqualified stock options (rights to buy)
Exercise: $14.26From: 2005-05-25Exp: 2015-05-25→ Common Stock (15,000 underlying)
Footnotes (5)
- [F1]Become exercisable in equal annual installments of 20% commencing 6/27/2008.
- [F2]Become exercisable in equal annual installments of 20% commencing 5/21/2009.
- [F3]Become exercisable in equal annual installments of 20% commencing 9/26/2010.
- [F4]Become exercisable in equal annual installments of 20% commencing 6/25/2011.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.64 to $18.75, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
MERIT MEDICAL SYSTEMS INC
CIK 0000856982
Entity typeother
Related Parties
1- filerCIK 0001192954
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 5:37 PM ET
- Size
- 18.7 KB